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“What is there in this world that truly makes living worthwhile? 
 Death thought about it. 
- CATS, he said eventually. - CATS ARE NICE.” 
-From Sourcery by Terry Pratchett 
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ABSTRACT
Very-high resolution ultrasound (VHRU, 25-55MHz) is a recently developed method 
for non-invasive assessment of vascular structures. With its increased ultrasound 
frequency, the method allows for noninvasive examination of the vascular wall in 
vivo with an axial resolution in the range of tens of micrometers. These 
characteristics make it a feasible method to determine vascular dimensions of 
superficial arteries and arteries in the pediatric population. This novel method has 
hitherto been validated for the assessment of arterial and venous wall layer thickness 
in children and young adults, but the opportunity to use border detection software 
to improve measurement characteristics, to assess vascular structures in preterm 
and term neonates, to assess intimal changes related with arterial aging, and to 
explore the clinical utility of the method in the assessment of inflammatory vascular 
disorders has not yet been investigated.  
The aim of this thesis was the following: 1. Broaden the toolbox for VHRU image 
analysis, that is, to study the application of a semi-automatic border detection 
software to improve measurement characteristics of the arterial wall layers, 2. To 
assess accuracy, precision and feasibility of the VHRU method in assessing superficial 
arterial wall layers in preterm and term neonates, 3. To validate the VHRU method 
to assess age-related intimal thickening of the arterial wall, and 4. To determine the 
potential to implement the method as a noninvasive tool in the bedside diagnosis of 
giant-cell arteritis of the temporal artery in the outpatient clinic. 
This Thesis shows that there is no significant difference in the technical precision or 
bias of arterial wall layer dimension measurements using a semi-automated border 
detection software compared to electronical calipers, but time of analysis is 
significantly shorter using the automated border detection software (71.5 ± 16.6s vs 
156.6 ± 37.2s, p<0.001), and the software can, therefore, be used for the automation 
of arterial wall layer dimension measurements.  
VHRU is feasible, accurate and precise in the measurement of arterial layer thickness 
(intima-media and intima-media-adventitia thickness) of proximal conduit arteries, 
such as carotid, brachial and femoral, in preterm and term neonates, whereas 
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conventional high-resolution ultrasound (HRU, <15 MHz) was limited by its resolution 
for this purpose. The resolution of VHRU is insufficient in the assessment of more 
peripheral conduit arteries such as the radial artery. The penetrance depth of VHRU 
is insufficient to assess the aorta. 
VHRU is feasible and able to detect a thickened intimal layer, seen as a four-line 
pattern of the arterial far wall in the ultrasound image, in superficial peripheral 
muscular conduit arteries with intima thickness >0.06mm. Measurements leading-
to-leading edge of the intimal layer are accurate compared with histological 
thickness (mean difference 0.007mm, 95% limits of agreement -0.042mm-0.057mm) 
and precise (coefficients of variation: intra-observer 15.7%, inter-observer 19.9%). 
The prevalence of intimal thickening increases with age. The validated method could 
potentially be used to monitor vascular health in the aging population. 
VHRU is feasible, accurate and precise in assessing histological transmural 
inflammation related intimal thickening in patients with giant-cell arteritis of the 
temporal artery. The method was however not useful in patients with inflammation 
limited to the adventitia or without inflammation on histology. VHRU derived intima 
thickness >0.3mm is more specific and clinically more useful in the detection of 
transmural inflammation compared with the halo-Doppler sign obtained with 
conventional HRU (receiver operating characteristic, ROC area under curve 0.99, 
CI95% 0.97-1.00 vs. 0.75, CI95% 0.54-0.96, p=0.026). Intimal thickening is detectable 
for a longer period after start of glucocorticoid treatment compared with the halo-
sign obtained with HRU. 
In conclusion, very-high resolution ultrasound is an emerging method for the 
assessment of superficial vascular wall layer structures. The harmless and non-
invasive method can detect near-microscopical changes in the vascular wall in human 
subjects from the newborn stage to old age. Very-high resolution ultrasound has a 
clinical potential in the non-invasive assessment of vascular health and disease 
related pathology. 
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INTRODUCTION
 
The development of ultrasonography has provided the possibility to non-invasively 
and without harm assess tissue structure and motion in vivo. Gradual equipment 
improvement of medical high-resolution ultrasound (HRU; 8-15 MHz) over time 
provided the opportunity to use ultrasound in the assessment of vascular structures 
in different populations.  
In 1986 Pignoli et.al described in their landmark study how to reliably determine 
vascular wall dimensions using B-mode ultrasonography.(1,2) By comparing 
histologic slides of the carotid artery with images taken using B-mode ultrasound of 
the same artery, they were able to demonstrate a double-line pattern in the 
ultrasound image of the elastic artery far wall. The first line was attributed to the 
ultrasound wave reflection at the blood to tunica intima -interphase, and the second 
reflection observed at the tunica media to tunica adventitia –interphase, with the 
distance between the interphases corresponding to the combined intima-media 
thickness (IMT).(3) 
Sonographic measurements of the carotid intima-media thickness (CIMT) has since 
been adapted as a surrogate marker for subclinical early atherosclerosis and risk 
stratification of cardiovascular disease events including coronary artery disease, 
stroke, and peripheral artery disease in research settings.(4,5) The utility of CIMT-
measurements for risk stratification in clinical settings has recently been disputed, 
and it has, as a consequence, been removed from the latest clinical guidelines.(6,7) 
In 2010 Sarkola et al. described the use of very-high resolution ultrasound (VHRU; 
25-55 MHz) for the analysis of the vascular wall layers in smaller muscular conduit 
arteries. The ultrasound frequency related improved resolution allowed arteries to 
be examined in more detail. A triple line pattern in the ultrasound image was 
described with the separate and simultaneous quantification of the far wall 
combined intima-media (IMT) and adventitia (AT) thickness. The measured thickness 
of the first reflection grossly overestimated the thin healthy intima layer thickness 
(IT) in animal specimens.(6) The increased resolution provided the opportunity to 
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image superficial muscular arteries IMT and AT not only in adults and adolescents, 
but in small children as well.(8) 
This thesis further develops the VHRU method. It implements new tools for image 
analysis, evaluates the use of VHRU to assess the arterial wall structure in preterm 
and term neonatal populations, assesses the clinical utility of VHRU in bedside 
outpatient giant cell arteritis diagnosis, and further validates the method for the 
quantification of IT in the aging adult population. 
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1. LITERATURE REVIEW
1.1 PRINCIPLES OF ULTRASOUND IMAGING
Ultrasonography is based on the reflection of acoustic waves moving in tissue. 
Piezoelectric elements in the transducer converts electrical energy to pressure 
waves.(9) As the sound wave propagates in the tissue, it will interact with the tissue 
creating reflections that are recorded and processed.(10) 
The acoustic impedance of tissue is the resistance of the tissue imposed on the 
propagating ultrasound beam. It is related to the density of the tissue influencing 
ultrasound propagation speed. The differences in impedance between different soft 
tissues is minute, whereas the acoustic impedance of bone is more than four times 
higher than that of soft tissue, and the acoustic impedance of air is immensely low 
resulting in diminished ultrasound reflections. 
 As the ultrasound beam reaches an interface of tissue with an increase in acoustic 
impedance, part of the acoustic wave will be reflected. The amount of reflected 
sound is directly related to the difference in acoustic impedance. Consequently, most 
of the ultrasound beam will be reflected at the border between soft tissue and bone. 
Both bone and air will thus limit imaging beyond the border. 
Brightness mode (B-mode) ultrasound is based on the ultrasound waves reflected 
and detected by the transducer.(11) In B-mode imaging, differences in the intensity 
and transmission time of the reflected wave are translated into a 8 bit grey-scale 
image.  
In optimal situations the tissue border is smooth and perpendicular to the ultrasound 
wave. In these occasions part of the wave will be reflected to the transducer and the 
rest will travel further through the tissue, i.e. specular reflection (Figure 1a). In the 
ultrasound image, the leading edge, defined as the surface of the bright reflection 
zone closer to the transducer, corresponds the true anatomical spatial tissue border. 
The leading edge is followed by a reflection trail ending in a trailing edge of the bright 
reflection zone. The thickness of the reflective trail, that is the distance between the 
leading and trailing edge, is independent of the thickness of the reflective tissue and 
is mainly related to ultrasound frequency and gain settings.  
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If the reflective interface is not completely smooth, part of the ultrasound beam will 
be scattered away from the transducer, reducing the intensity of the returning 
ultrasound wave, i.e. diffuse reflection (Figure 1b). If the ultrasound beam hits a 
surface with an angle that is not perpendicular to the soundwave, the reflection will 
divert away from the transducer, i.e. refracted, reducing image quality (Figure 1c). 
The ultrasound beam will further interact with small structures causing the 
ultrasound beam to scatter in all directions (Figure 1d). 
 
Figure 1. Different kinds of ultrasound reflection: a) specular reflection, b) diffuse 
reflection, c) refraction, and d) scattering. 
 
Image resolution and imaging depth are important factors to consider when imaging 
vascular structures, and both are related with ultrasound frequency.(12) Whereas 
the resolution increases with frequency, the imaging depth or the penetrance is 
reduced. The main categories of resolution are the following (Figure 2a):  
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1. Temporal resolution, the smallest time interval at which two different events can 
be separately distinguished. A high temporal resolution is important when measuring 
movement of e.g. the arterial wall or the heart. The temporal resolution is related to 
the transmission time, and therefore the imaging depth, and the number of scan 
lines.  
2. Axial resolution is the ability to spatially distinguish two points in the depth of the 
image. The axial resolution is of great importance when assessing different layers of 
the vascular wall with ultrasound. It corresponds directly to the wavelength and, 
thus, the frequency of the transducer as follows:  
 ? ? ???  
Where d is the axial resolution, and λ is the wavelength. The wavelength is related to 
the propagation speed in tissue (c, on average 1540m/s in soft tissue) and the 
frequency, f, as follows: 
? ? ??? 
And the axial resolution??
? ? ???? 
Higher frequencies then provide a smaller pixel size in the axial direction and 
improved resolution (Figure 3a).(13) 
3. Lateral resolution is the ability to distinguish two points in the plane of the 
transducer. The lateral resolution is dependent on the beam width, that is related to 
width of the apparatus, the wavelength, and the depth. The lateral resolution varies 
across the image and is highest at the focal point after which it diminishes. 
4. Out-of-plane resolution or slice thickness resolution is the ability to distinguish the 
plane from surrounding areas, i.e. the thickness of the field of view. The out-of-plane 
resolution is usually similar to the lateral resolution and is important when imaging 
small arterial structures bordering the resolution limit (Figure 2b).(14) 
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Figure 2. Schematic images a) of different spatial resolutions of ultrasound, and b) 
how the different resolutions affect imaging of vascular structures in the transverse 
plane. The axial resolution determines if two independent layers can be separately 
viewed, whereas insufficient out-of-plane resolution may distort the image leading to 
inexact measurements. 
 
Imaging depth, the penetrance, of ultrasound is influenced by the output intensity of 
the ultrasound beam and the attenuation of ultrasound in tissue. Attenuation is the 
rate at which the ultrasound beam weakens when passing through tissue. When the 
sound wave propagates in the tissue, part of the energy from the wave will be 
absorbed by the tissue and converted to heat, part will be reflected at tissue 
interfaces and part will be diverged away from the transducer.(9)  
The gradual absorption of energy increases for shorter wavelengths and higher 
ultrasound frequencies. As the output intensity is relatively constant between 
devices, the penetrance depth is mainly related to tissue density and inversely 
related to ultrasound frequency.(15) The penetrance depth in soft tissue of typical 
ultrasound systems can be calculated as approximately: 
???? ? ???? ? ? or ???? ? ??? ? ??? 
Where Dmax is the maximal penetrance distance of the ultrasound system, λ is the 
wavelength, c is the propagation speed in tissue, and f is the frequency of the 
transducer (Figure 3b).(13,16) 
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Figure 3. The relationship of a) ultrasound transducer frequency and axial resolution 
and b) ultrasound transducer frequency and penetrance for high-resolution 
ultrasound (HRU) and very-high resolution ultrasound (VHRU). 
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The choice of transducer is, thus, a balance between penetrance and resolution.(17) 
The frequency should be low enough to allow sufficient penetrance, but high enough 
to optimize image resolution. In a clinical setting, the frequency range of ultrasound 
is typically 2-20 MHz, with the lower frequencies mainly used for scanning of deeper 
targets such as organs in the abdominal cavity.(11) Smaller and superficial structures 
including blood vessels require a higher frequency to be appropriately assessed in 
the near field. Still, the highest frequencies currently applied in a clinical setting (15-
20MHz) are limited by the axial resolution when imaging peripheral smaller muscular 
conduit arteries and arteries in small children.(18) 
1.2 ARTERIAL AGING
The large and medium sized arteries are divided into categories of elastic and 
muscular arteries differing by size and histology. The elastic arteries are the arteries 
most proximal to the heart, such as the aorta, subclavian, carotid and iliac arteries. 
The muscular conduit arteries are smaller and distal to the elastic arteries. Most of 
the further named arteries, such as the brachial, femoral and radial arteries are 
muscular arteries.(19) 
The arterial wall of large and medium sized arteries is divided into three layers: the 
intima, the media, and the adventitia, each separated by two elastic laminae (Figure 
4a and 4b).(20,21) The intima consists of a layer of endothelial cells supported by a 
layer of elastic tissue (internal elastic lamina, IEL). In healthy arteries, the intimal 
thickness is very thin, often difficult to quantify and measuring 10-30 μm on 
histological sections. 
The media is the thickest layer of the arterial wall with a thickness ranging from 600-
1000 μm for the aorta and 50-150 μm for smaller muscular arteries, such as the radial 
and coronary arteries.(8,22) In elastic arteries the media consist of smooth muscle 
cells and circumferential elastic fibers, whereas the media of muscular arteries 
consists predominantly of smooth muscle cells.(20)  
The outermost elastic layer of the media is called the external elastic lamina (EEL), 
underneath which lies the adventitia. The structure of the adventitia varies between 
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arteries and locations and consist generally of an inner compact and an outer loose 
layer of elastic fibers and connective tissue.(23) 
Arterial aging starts during childhood.(24-30) Throughout life the arterial wall will be 
exposed to shear stress, oxidative stress and inflammation leading to endothelial 
dysfunction and remodeling of the arteria wall. There will be increased amounts of 
collagenous fibers and a reduction in smooth muscle cells and elastic fibers, with 
fragmentation of the elastic laminae resulting in increased arterial stiffness.(31-37)  
Smooth muscle cells will further migrate to the intimal layer causing diffuse intimal 
thickening (Figure 4c).(38-41) Diffuse intimal thickening is seen as an adaptive 
physiological process in vascular ageing and not considered part of the atherogenic 
process.(42) Evidence, however, suggest that there’s a link between cardiovascular 
morbidity and diffuse intimal thickening, and that intimal thickening is more 
abundant in atherosclerosis prone regions.(43,44) One suggested mechanism is that 
diffuse thickening of the intima damages the endothelium increasing its permeability 
for lipids. It will, thus, allow for lipid accumulation in the vascular wall. A lipid-driven 
inflammation will further lead to plaque formation and calcification (Figure 4d).(45-
49)  
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Figure 4. Histology of a) and b) a temporal artery without evident intimal thickening 
or remodeling of the vascular wall, c) a temporal artery with diffuse intimal 
thickening, and d) a temporal artery with diffuse intimal thickening and focal 
calcification of the vascular wall. AT – adventitia; CAL – Calcification; IEL – Internal 
Elastic Laminae; IT – Intima; MT – Media. 
 
  
22 
 
1.3 ASSESSMENT OF THE ARTERIAL WALL USING ULTRASOUND
As the ultrasound waves travel through the vascular wall it will cause a reflection at 
the interface of two mediums of different acoustic impedance. The leading edge 
corresponds to the true tissue border, whereas the trailing-edge reflects scatter in 
tissue related to transducer frequency and gain setting.  
The acoustic impedance changes with the histological layers of the arterial wall and 
will thus cause echogenic reflections at the borders with intermediate echolucent 
regions. If the resolution is sufficient, there will be four reflective regions in the 
arterial wall, whereas insufficient resolution will cause fusion of the regions in the 
ultrasound image.  
The first reflection appears at the lumen-intima interface as the acoustic impedance 
increases from blood to intima wall tissue (Z1). The second reflective region is at the 
internal elastic lamina between the intima and the media as elastin has a higher 
acoustic impedance than the surrounding layers (Z3). The third reflection is similarly 
at the external elastic lamina between the media and the adventitia (Z5). The last 
reflection appears at the edge between the adventitia and the perivascular tissue 
(Z7).(3,50,51) The intermediate zones Z2, Z4, and Z6 are variably echolucent regions 
without ultrasound reflection. Arterial wall layer thickness measurements with 
ultrasound are based on the distance between different reflective zones. These 
seven echo zones of the arterial wall (Z1-7) are schematically presented in Figure 5 
and will be referred to throughout this thesis.  
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Figure 5. Schematic image of the different reflective zones and their histological 
counterparts of the arterial wall. Z1- Zone 1, reflection at the border of the vascular 
lumen and the intima; Z2 – Zone 2, echolucent intima zone; Z3 – Zone 3, reflection 
from the internal elastic lamina; Z4 – Zone 4, echolucent media zone; Z5 – Zone 5, 
reflection from the external elastic lamina; Z6 – Zone 6, echolucent adventitia zone; 
Z7 – Zone 7, reflection from the adventitia and vascular wall border. Note that the 
histological borders correlate with the leading edge of the reflection. AT – Adventitia 
thickness; EEL – External elastic lamina; IEL – Internal elastic lamina; IT – Intima 
thickness; LD – Lumen diameter; MT – Media thickness. 
 
In 1986 Pignoli et al. first published their research on carotid artery ultrasound and 
described the double line pattern seen in the carotid artery far wall. It was shown to 
correspond to the intima-media thickness (IMT) of the artery (Figure 6). (1,2) The 
results were further confirmed by multiple independent groups stressing the 
importance of measurements performed at the far wall (rather than the near wall) 
and using the leading-to-leading edge technique. (52-54)  
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Figure 6. Schematic and ultrasound images of a carotid artery using a 25MHz 
transducer. Note how the intima and adventitia are not distinguishable and the echo 
zones Z1-3 and Z5-7 are fused.  IMT – Intima-media thickness; LD – Lumen dimension. 
Modified from Sundholm et.al. 2019 (III). 
 
Carotid artery intima-media thickness (CIMT) has since then been confirmed as an 
independent predictor of cardiovascular disease including stroke and is widely used 
as a surrogate marker for cardiovascular disease in research settings.(55-62) The 
relevance of CIMT measurements in clinical settings has lately been disputed, as the 
evidence of added prognostic values is contradictory. Some studies suggest that 
there is no evident increase in prognostic value compared to traditional risk scores, 
e.g. the Framingham score.(63,64) As a result CIMT measurements are no longer 
recommended  in the latest clinical guidelines.(6,7)  
The limitations of the methods are suggested to be related to a non-pathological age 
related increase in CIMT, whether measurements are done in the common or 
internal carotid areas, inclusions of plaques, and inevitable technical variation in the 
measurement.(65,66) 
These limitations increase the need for rigid and standardized measurement 
protocols and minimization of technical variance e.g. using automated measurement 
systems and comparing measurements with references for age.(66-68) 
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1.4 VERY-HIGH RESOLUTION ULTRASOUND
The use of very-high resolution ultrasound (VHRU, 25-55MHz) has during the last 
decade been adopted in the assessment of vascular morphology in vivo.(18,69) It was 
primarily developed for preclinical use and mainly to investigate anatomy and 
pathology of organs in small mammals.(70,71) The higher frequencies of this method 
allow the visualization of the vascular wall structure in almost microscopical detail 
(axial resolution 0.015-0.033mm), and limited mainly by its penetrance (as seen in 
Figure 3), allowing imaging of superficial peripheral conduit arteries and vascular 
imaging in small children.(8,18) 
VHRU derived measurements of peripheral artery IMT has been shown to be 
applicable in different populations and study settings, and has been suggested as a 
surrogate marker for cardiovascular disease similar to CIMT.(72-77) VHRU has 
further been shown to be beneficial when assessing vascular wall damage as a 
sequalae to intravascular and surgical interventions and as an aid for vascular access 
and cannulation.(78-82)  
Different non-invasive ultrasound derived estimations of the adventitia thickness 
(AT) of the carotid artery has previously been attempted using HRU. The total arterial 
wall thickness was defined by Hodges et. al. as the distance from the far wall arterial 
lumen to the trailing edge of the echogenic zone surrounding the IMT (Z5-7) showing 
great repeatability but without histological verification.(83) Skilton et al. introduced 
the concept of extra media thickness. They measured the distance from the leading 
edge of the echogenic zone at the lumen - far wall interface of the jugular vein to the 
trailing edge of the adventitia to media transition area (EEL) of the common carotid 
near wall. The extra media thickness method was reported to reflect carotid artery 
AT, but inevitably included perivascular tissue. The method was introduced without 
histological verification.(84,85) Since then a handful of studies have assessed the 
relation of extra media thickness with cardiovascular disease.(86-88) These methods 
are, however, limited by lack of proper validation. 
Early in vitro validation of the VHRU method on animal arterial specimen showed a 
distinct triple line pattern in muscular arteries with the method reported as an 
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extension to the traditional double-line pattern method originally validated for the 
carotid artery IMT assessment (Figure 7a). Leading-to-leading edge measurements 
of the separated Z5-Z7 in the triple line ultrasound image corresponded to the 
histological AT. A similar pattern was, however, not seen in elastic arteries, and this 
was speculated to be related to differences in the composition of the adventitia in 
the different artery types. (18)  
The increased resolution of VHRU frequencies and experiences of intima layer 
assessments using intravascular ultrasound (IVUS) also generated an interest of 
applying non-invasive VHRU for the assessment of superficial conduit artery IT. In 
2001 Rodriguez-Macias et.al. reported on a method assessing IT measuring the 
leading-to-trailing edge distance of the first echogenic zone of the artery far wall with 
a 25MHz transducer. The authors concluded that the ultrasound-derived IT 
overestimated the histological IT.(89) The VHRU-IT method was later in 2007 
validated by Osika et al with 55 MHz, using silicone phantoms and mesenteric 
arteries with evident intimal thickening (100-400μm), but without histological 
validation in the peripheral muscular conduit artery IT range (<100 μm).(69) Since 
then the leading-to-trailing edge method has been further evaluated, and its use as 
a surrogate marker for cardiovascular disease has been assessed in multiple 
studies.(90-99) The interpretation of these results is difficult due to the controversial 
validation of the method based on a leading-to-trailing edge principle.  
The leading-to-trailing edge method has been disputed, as the accuracy of the trailing 
edge border is influenced by ultrasound scatter, and the thickness of the ultrasound 
reflection is independent of the thickness of the structure generating the reflection. 
(3,68)  Sarkola et.al. compared VHRU measurements of IT obtained with the leading-
to-trailing edge method, as suggested by Osika et al (70), with histology IT in healthy 
animal arterial specimens. They found that the VHRU derived IT grossly 
overestimated histological IT and showed no correlation with histological IT. They 
concluded that the variability observed in the VHRU IT measurement of the healthy 
artery using the Osika method is due to technical variability in the VHRU leading-to 
trailing edge measurement (i.e. background noise), and that the healthy artery IT is 
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below the axial resolution limit and, thus, beyond the resolution of VHRU 
frequencies.(18)  
Vatanen et.al. recently described a distinct four-line pattern of the arterial far wall 
obtained with VHRU among long-term child cancer survivors that was related with 
radiotherapy in early childhood. The four-line pattern allowed IT measurements 
leading-to-leading edge within the near blood intima region, and this was interpreted 
to represent diffuse intimal thickening allowing ultrasound quantification of IT. 
However, their measurements were reported without histological verification 
(Figure 7b).(100) 
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Figure 7. Schematic and ultrasound images (55MHz) of radial arteries with a) no 
intimal thickening, showing the triple-line pattern, note how the intima is beyond the 
axial resolution and zones Z1-3 are fused, and b) intimal thickening seen as a four-
line pattern with seven distinct echo zones (Z1-Z7). The scale bar represents 1mm.  LD 
– Lumen dimension IT – Intima thickness; IMT – Intima-media thickness; MT – Media 
thickness; AT – Adventitia thickness. Modified from Sundholm et.al. 2019 (III).  
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1.5 BORDER DETECTION SOFTWARE
Measurements of arterial wall dimensions using manual electronical calipers (EC) are 
time consuming and prone to technical variation due to interobserver variability in 
image interpretation.(68,101) The development of semi-automated and later fully 
automated border detections software were initiated to address these 
issues.(3,102,103)  
There are now multiple software available that use different algorithms to identify 
the borders of the lumen and the vascular wall, either with the aid of human 
supervision or fully automated.(102-109) The commercially available systems are 
developed for HRU systems and do not currently support measurements of intima or 
adventitia thickness. The software is limited mainly to CIMT and plaque identification 
and have not been validated for analysis of VHRU images. 
The main benefits of border detection software include less interobserver 
dependence and variability over time avoiding measurement drift. The semi-
automated systems still slightly outperform the fully automated 
systems(101,110,111), and their use are recommended by current 
guidelines.(7,67,112) The software currently available are, however, validated for 
IMT and plaque measurements only. 
1.6 ULTRASOUND DIAGNOSTICS OF GCA
1.6.1 GIANT CELL ARTERITIS OF THE TEMPORAL ARTERY
Giant cell arteritis (GCA) is an inflammatory vasculopathy affecting predominantly 
medium and large size vessels that has a well-defined adventitial vasa vasorum.(113-
115) It is the most common primary vasculitis with a global incidence of 10/100 000 
and an even higher incidence in northern Europe (20/100 000).(116-119) The peak 
incidence is between ages 70 and 80 years, and the disease is rarely seen among 
individuals younger than 50 years old. 65-75% of affected individuals are women, and 
there is a 50% comorbidity with polymyalgia rheumatica.(119-121) 
The inflammation in GCA is to be derived from activation of dendritic cells in the vasa 
vasorum around the vascular wall.(122,123) The activated dendritic cells infiltrate 
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the vascular wall recruiting CD4+ T-cells and macrophages causing 
inflammation.(124) There is an increased matrix metalloproteinase activation and 
smooth muscle cell migration to the intima causing destruction of the elastic laminae 
and intimal hyperplasia.(125-127) The intimal hyperplasia can cause lumen occlusion 
and ischemic complications distal to the inflammation. Visual loss is the most feared 
ischemic complication seen in around 15% of untreated patients.(128,129) 
The golden standard for GCA diagnosis is biopsy of the temporal artery showing 
marked inflammation of the vascular wall.(130-132) The biopsy is, however, not 
flawless. The inflammation may be segmental causing false-negatives. The sensitivity 
ranges from 32-90%, with reduced sensitivity in patients with predominantly extra-
cranial large vessel vasculitis and/or prolonged glucocorticoid treatment.(133-140) 
Biopsy of the temporal artery is further an expensive and invasive  procedure and, 
even though complications are scarce, it is not risk free. Furthermore, it is not 
applicable for follow-up assessments.(141-143) 
1.6.2 THE HALO-SIGN IN HIGH-RESOLUTION ULTRASOUND
In 1997 Schmidt et al. described a hypodense perivascular halo sign in the temporal 
artery of patients with GCA using colour Doppler HRU (Figure 8).(144) The halo-sign 
was described to represent the oedematous and thickened vascular wall. Thus, grew 
the interest to refine this non-invasive tool for GCA diagnostics.(145-158)  
The halo-sign was shown to be specific and sensitive in the setting of transmural 
inflammation, with a sensitivity of 68-75% and a specificity of 83-91% for an 
unilateral halo sign and a specificity of 100% for a bilateral halo sign with slight 
reduction in sensitivity (46%), confirmed by meta-analyses.(159-163) 
A major drawback of the method is significant loss of sensitivity after only 2-4 days 
glucocorticoid treatment.(164) A further limitation is the operator dependency and 
subjectivity of the interpretation leading to variable results. There has been a call for 
standardization of imaging protocols to refine the diagnostic process.(165,166) For 
instance, cut-off values for diagnosis have been reported to reduce the rate of false 
positives.(157,167,168).  
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Figure 8. The perivascular halo-sign diagnostic for giant-cell arteritis as seen with a 
15MHz transducer. DA – Colour Doppler representing the blood flow of the lumen; HA 
– a dark halo surrounding the lumen, representing an oedematous, thickened 
vascular wall. Modified from Sundholm et.al. 2019 (IV). 
 
The method is robust and the halo sign has been included in the latest EULAR 
recommendations for diagnostic criteria of GCA as an alternative to temporal artery 
biopsy.(169-172) So far only a handful of studies has assessed the utility of VHRU for 
the assessment of temporal artery morphology in GCA in small samples and without 
diagnostic utility assessment, or comparison to HRU. (173-176) 
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2. OBJECTIVES
 
I. To assess the feasibility of a semi-automatic border detection software on 
very-high resolution ultrasound images and explore benefits regarding 
analysis time and precision compared with manual electronic calipers. 
 
II. To study the feasibility, accuracy and precision of non-invasive very-high 
resolution ultrasound to assess arterial wall morphology in preterm and 
term neonates in vivo, and to compare the method with conventional 
high-resolution ultrasound. 
 
III. To validate the very-high resolution ultrasound derived four-line pattern, 
in comparison to histology, as a method to quantify arterial intima 
thickness non-invasively in vivo. 
 
IV. To study the clinical diagnostic utility of very-high resolution ultrasound 
in comparison with conventional high-resolution ultrasound in the 
assessment of temporal artery manifestations of giant cell arteritis. 
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3. METHODS
3.1 RESEARCH SETTING AND STUDY DESIGN
This study was carried out at the Children’s Hospital, Helsinki University Hospital, 
between 2011 and 2018. All studies are prospectively recruited cross-sectional 
studies.   
3.2 ETHICS
The local research ethics board approved the study and written informed consent 
was obtained from patients and from parents of minors. Permission to use the Vevo 
770 equipment (Visualsonics, Toronto) for studies on human subjects was obtained 
from the Finnish National Supervisory Authority for Welfare and Health, Valvira. 
3.3 STUDY POPULATIONS
3.3.1 STUDY I
The study population of study I consisted of 10 healthy subjects of both sexes, 
including both adults and children (age range 5-56 years). The population was 
investigated at two occasions two weeks apart between December 2011 and January 
2012. Exclusion criteria were previously diagnosed cardiovascular disease and 
previous surgical or intravascular interventions to carotid, brachial, radial, femoral or 
posterior tibial arteries assessed in the study.  
3.3.2 STUDY II
The study population consisted of 25 neonates of different gestational ages (range 
from 33+0 to 41+5 weeks) and weights (range from 1570 to 4950 gram) recruited 
between November 2011 and January 2014 within 3 days of delivery at the Women's 
Hospital, Helsinki University Hospital. Subjects with cardiac or extra cardiac 
malformations, or medication affecting the cardiovascular system during the 
antenatal or postnatal periods were excluded. 
3.3.3 STUDY III AND IV
 For study III and IV we recruited 74 (study III) and 78 patients (study IV) with 
suspected giant cell arteritis (ages 40-86 years) referred to the unit of Vascular 
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Surgery at Helsinki University Hospital for biopsy of the temporal artery between 
August 2015 and May 2018.  
Study III and IV excluded subjects with failed biopsy (N=3). Study III further excluded 
all patients with any sign of inflammation on temporal artery biopsy (N=20), biopsies 
sectioned diagonally precluding reliable assessment of vascular dimensions on 
histology (N=8), and patients missing vascular VHRU images of sufficient resolution 
due to equipment breakdown (N=6), with 37 subjects included in the final analysis.  
Study III further included a convenience sample (N=380) recruited in other previous 
or current ongoing longitudinal research projects consisting of 1. young healthy 
children and adolescents (age 0-18 yrs., n=139 (8)), 2. teenagers with type 1 diabetes 
(age 13-16 yrs., n=39, unpublished), 3. healthy males (age 20-46 yrs., n=24, 
unpublished), and 4. a sample of  women with obesity and or gestational diabetes 
(age 28-51 yrs., n=178, unpublished). 
3.4 ULTRASOUND EQUIPMENT AND IMAGE ANALYSIS SOFTWARE
3.4.1 VERY-HIGH RESOLUTION ULTRASOUND SYSTEMS (VHRU)
Very-high resolution images were obtained using Vevo 770 (VisualSonics, Toronto, 
Canada, 2005) for study I-II and for the first 41 subjects of study III-IV, and using Vevo 
MD (VisualSonics, Toronto, Canada, 2016) for the remaining subjects in study III-IV. 
The technical details of the VHRU devices and their transducers are shown in Table 
1. 
3.4.2 CONVENTIONAL HIGH-RESOLUTION ULTRASOUND (HRU)
Conventional HRU systems in this study were GE Vivid 7 (GE Healthcare, Chicago, IL, 
USA, 2001) equipped with 7 MHz and 12MHz transducers (study II), and for study IV, 
GE LOGIQ e (GE Healthcare, Chicago, IL, USA, 2015) equipped with a 18MHz vascular 
transducer for the first 41 subjects and the Vevo MD equipped with a 15MHz 
transducer for the rest. 
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Table 1. Very-high resolution ultrasound systems and the transducers used in this 
study. From the supplemental material of Sundholm et.al. 2019 (III), used with 
permission from Elsevier 
 
3.4.3 IMAGING PROTOCOL
All images were obtained at rest in supine position. Care was taken not to compress 
the artery and the highest frequency allowing visibility of the far wall was used. 
Images were recorded perpendicular to the vascular wall, with gain settings and focal 
depth adjusted to reduce scatter, and to optimize image quality.  
Images of the carotid artery for measurements of vascular dimension were 
processed according to guidelines(4) 1 cm proximal to the bulb (study I-III) and the 
arteries were further screened for plaques throughout the bulb and bifurcation as 
Ultrasound System Vevo 770 Vevo MD 
Release Year 2005 2016 
Transducer type Single Mechanical Multiple electrical 
Image post-processing None Despeckling filter 
Multi-focus No Yes 
Transducers RMV710B UHF22 
Centre transmit 25MHz 15MHz 
Frequency range 12-38MHz 10-22MHz 
Axial Resolution 70μm 100μm 
Penetrance 22.5mm 38.4mm 
Transducers RMV712 UHF48 
Centre transmit 35MHz 30MHz 
Frequency range 17-53MHz 20-46MHz 
Axial Resolution 50μm 50μm 
Penetrance 13.0mm 23.5mm 
Transducers RMV708 UHF70 
Centre transmit 55MHz 50MHz 
Frequency range 22-83MHz 29-71MHz 
Axial Resolution 30μm 30μm 
Penetrance 8.0mm 10.0mm 
36 
 
far as visibility allowed (study III).  The radial artery was imaged 1 cm proximal to the 
palma manus (study I and III), the brachial artery 2 cm proximal to the cubital skin 
fold (study I-III), the femoral artery at the inguinal skin fold (study I-II) and the 
posterior tibial artery at the level of the medial malleolus (study I). The temporal 
artery was screened from the zygoma arch distally throughout the common temporal 
artery (study III-IV), as well as the parietal and frontal branches after bifurcation. 
Images were stored as moving video clips and later analyzed offline. 
3.4.4 IMAGE ANALYSIS SOFTWARE
VHRU images were analyzed using manual electronic calipers using vendor software 
Vevo 3.0.0 (Vevo 770) and VevoLab 2.0.0 (Vevo MD) (Study I-IV), and dimensions 
calculated as a mean of three measurements. In study I we further used a semi-
automated border detection software (AMS, Arterial Measurement System (103) 
gustav@alumni.chalmers.se). GE Vivid 7 images were analyzed in AMS using 
electronic calipers, and GE LOGIQ e images using ImageJ 1.51J8 (National Institutes 
of Health, USA,(177)). 
3.4.5 IMAGE ANALYSIS PROTOCOL
Vascular dimensions were measured from the far wall in end-diastole using the 
leading-to-leading edge method. Lumen diameter (LD) was defined as distance from 
the leading edge of the near wall intima-lumen interphase to the far wall leading 
edge of intimal-lumen interphase (Z1). Intima-thickness (IT) was measured from 
leading edge of Z1 to the leading edge of Z3. Intima-media thickness (IMT) was 
measured from leading edge of Z1 to leading edge of Z5. Intima-media-adventitia 
thickness (IMAT) was measured from leading edge of Z1 to leading edge of Z7. (Figure 
5 & 9.) Adventitia thickness was calculated as the difference between IMAT and IMT. 
Image quality was subjectively graded into high or low quality according to visibility 
of the far wall in the ultrasound clip.  
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Figure 9. Schematic images showing how leading-to-leading edge measurements of 
the far wall were performed, and corresponding dimensions in a) arteries with 
double-line pattern, b) arteries with triple-line pattern, and c) arteries with four-line 
pattern. Echo zones are defined in Figure 5 IT – Intima thickness; Intima-media 
thickness; MT – Media thickness; AT – Adventitia thickness; LD – Lumen dimension. 
 
Carotid arteries were evaluated for plaques (study III) according to the Mannheim 
consensus, defining a plaque as a focal thickening of IMT fulfilling one of the following 
criteria 1. IMT>1.5mm, 2. IMT increase of 0.5mm, or 3. >50% compared to the 
surrounding IMT. (67) 
The perivascular Halo-sign in patients with suspected GCA was evaluated both 
subjectively and measured as a ratio of the perivascular halo area to Doppler lumen 
area as follows: HRU-HDR = Halo-area/doppler-area (Figure 10.) 
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Figure 10. Calculations of halo-doppler ratio from conventional high-resolution 
images. HDR – Halo-doppler ratio; HA – Halo-area; DA – Doppler area. Modified 
from Sundholm et.al. 2019 (IV). 
 
Intra-observer agreement was assessed by independently repeated analyses of the 
ultrasound clips performed by the primary investigator. For inter-observer 
agreement, the images were independently analysed by a second investigator. For 
test-retest variability (reproducibility), images of the same subject from two different 
imaging sessions were measured by the primary investigator (study I-II).  
Measurement of Vevo images using AMS required extraction of a single image 
converted to lossless TIFF-format prior to analysis. Measurements were done in a 1-
2cm wide region of interest automatically traced by the software. Manual correction 
of the traced borders was done only when deemed necessary by the operator. 
Analysis time was assessed for 20 individual clips using both electronical calipers and 
AMS (Study I). 
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3.4 HISTOLOGICAL PROCESSING
Biopsy of the temporal artery was done as routine diagnostics at Helsinki University 
Hospital Department of Vascular Surgery. The biopsy was fixed in formalin and cut in 
transverse sections (multiple levels) and stained with haematoxylin and eosin (H&E) 
and Verhoff’s elastic stain (VEG).(178) Uncertain cases where further stained using 
T-lymphocyte CD3+ immunohistochemical stain.(179)  
Biopsies were evaluated for vascular pathology at a certified pathology unit of the 
Helsinki University Hospital (HUSLAB).  Histological assessments of vascular 
dimension were evaluated using optic microscopy (Nikon Eclipse 80i & Digital Sight 
DS-5M, Tokyo, Japan) photographed at 10x zoom, and vascular dimensions 
measured offline in ImageJ 1.51J8 using electronic calipers. Measures were 
calculated as the mean of 10 measurements to avoid focal variations in the vascular 
wall, with IT, IMT, and AT measured separately.  
3.5 DIAGNOSTICS OF GIANT CELL ARTERITIS 
Giant-cell arteritis diagnosis was determined on histological and clinical basis. The 
biopsy was deemed negative if there was no inflammation on histology (Figure 11a), 
or only mild inflammation limited to the perivascular area and/or the vasa vasorum 
as the significance of perivascular inflammation is controversial.(180)  A biopsy with 
inflammation limited to the adventitia (ILA, Figure 11b) or transmural inflammation 
(TMI, Figure 11c and d)  were defined as positive and diagnostic for GCA. Subjects 
with a negative biopsy were evaluated by an expert rheumatologist and final 
diagnosis was assessed on the basis of clinical findings, laboratory results, response 
to treatment, evidence of large vessel vasculitis on positron emission tomography 
(PET-CT) or magnetic resonance imaging (MRI), and a differential diagnostic work-up 
during a 6 month follow up from biopsy procedure. (181-189) 
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Figure 11. Histology of Verhoff’s elastic stain (A) of a temporal artery without 
inflammation (“No GCA” and “Clinical GCA without inflammation” groups). Histology 
of haematoxylin and eosin stain (B) of a temporal artery with minor inflammation 
limited to the adventitial layer (ILA). Note the streak of inflammatory cells throughout 
the media-adventitia border. Verhoff’s elastic stain (C) and haematoxylin and eosin 
stain (D) of a temporal artery with transmural inflammation (TMI). AT – Adventitia; 
IT – Intima; L – Lumen; MT – Media. From Sundholm et.al. 2019 (IV). 
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3.6 DATA ANALYSIS
Results are reported as mean with SD for continuous normally distributed variables, 
median and range for non-normally distributed continuous variables, and 
proportions for categorial variables. Shapiro-Wilk test was used to test normality.  
Group comparisons were done using Student’s T-test for continuous variables. 
Multiple groups were compared using ANOVA for normally distributed variables with 
post-hoc Bonferroni, Kruskal-Wallis for non-normally distributed continuous 
variables with post-hoc Dunn-Bonferroni, and Fisher-Freeman-Halton for categorial 
variables with post-hoc independent Fisher comparisons including Bonferroni 
adjusted levels of significance.  
Agreement was quantified by calculating the mean difference, 95% limits of 
agreement (LOA), coefficient of variation (CV), and intraclass correlation coefficients 
(ICC), and further visualized using Bland-Altman plots.(190)  
Multiple linear and logistic regression models were used to assess the relationship 
between scalar respectively dichotomous variables, and multiple explanatory 
variables.  
Diagnostic performance was assessed using receiver operator characteristics-curves 
(ROC) and methods were compared using a paired test of equality for area under 
curve (AUC).(191) Cut-off values for different parameters were evaluated using 
sensitivity-specificity charts optimizing positive likelihood ratio (LHR+), and results 
reported using sensitivity, specificity, LHR+ and negative likelihood ratio (LHR-) 
For all analyses a p-value of <0.05 was deemed statistically significant. Data analysis 
was performed using SPSS (IBM, NY, USA, study I-IV) and Stata MP (Stata corp., TX, 
USA, study III-IV).  
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4. RESULTS & DISCUSSION
4.1 STUDY I, AUTOMATED BORDER DETECTION SOFTWARE
One benefit of the semi-automated system was the shorter analysis time for a single 
image, with a reading time of 71.5 ± 16.6s for the semi-automated system (AMS) and 
156.6 ± 37.2s for electronic calipers (EC) (p<0.001).  
Intra- and interobserver as well as test-retest variabilities were similar for AMS and 
EC with no evident bias (Table 2-4, Figure 12). This is partly in disagreement with 
previous studies comparing manual measurements with semi-automated systems, 
where a systematic underestimation of IMT has been reported with semi-automated 
systems compared to manual caliper measurements, but with an improved technical 
measurement reliability.(192-195) This disagreement could be explained by a 
resolution mismatch with AMS primarily developed for lower resolution ultrasound 
images. Furthermore, the AMS software does not fully support VHRU image 
processing, which leads to increased manual interference.(103) This may have 
influenced measurement time as our analysis time for AMS was longer than 
previously reported for conventional ultrasound image processing.(108,196-198) 
 The lack of image preprocessing may also have influenced our results. We did not 
normalize image gray-scale or use despeckling filters which has been recommended 
by some to improve the border detection for automated systems.(199,200)  
In a multiple linear regression model (R2 = 0.171) the operator technical variability 
(CV%) was mainly predicted by 1. dimension size with increased relative variability 
for smaller dimension measurements (logarithmic relationship; 
R2 = 0.125, β = −4.800, p < 0.001), 2. image quality (R2 = 0.015, B = −2.446, p < 0.001), 
and 3. repeat imaging (test-retest) (R2 = 0.025, B = 2.669, p < 0.001). There was no 
statistically significant effect of observer (inter-observer) or software (R2 = 0.002, 
p = 0.169, and R2 = 0.000, p = 0.450 respectively). Whereas dimension size has 
previously been shown to be related to increased relative variability, we did not find 
any earlier reports investigating the effect of image quality.(201)  
We concluded that AMS as a semi-automated border detection software performs 
equally well compared to electronic calipers with significant shorter analysis time.  
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The main limitations of the study were the small sample size and inclusion of only 
healthy subjects with an age span not including infants or patients with marked 
cardiovascular disease. This precluded comparison of results between different age 
groups and effect of cardiovascular disease.  Also, the assessment was performed 
with one software only. We did, however, include both children and adults, assessed 
the utility of AMS in multiple arterial locations, and included both elastic and 
muscular arteries in our study.  
 
Figure 12. Bland–Altman plots on semi-automated border detection software- (AMS) 
and electronic caliper-derived (EC) derived intra (A–C), inter (D–F), and test-retest (G–
I) agreements for lumen dimension (LD), intima-media thickness (IMT) and adventitia 
thickness (AT) measurements. Mean difference and 95% limits of agreement are 
displayed with lines for both systems. From Sundholm et.al. 2014 (I), with permission 
from Elsevier. 
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4.2 STUDY II, FEASIBILITY, ACCURACY AND PRECISION OF VHRU IN 
NEONATES
The more superficial location of arteries in neonates, compared to adults, allows the 
use of higher frequencies for vascular imaging in the near field. We found that the 
carotid and femoral artery far wall was visible using a 35MHz transducer in all 
subjects, and the brachial artery visible in all using a 55MHz transducer. The femoral 
artery was visible using a 55MHz transducer in all neonates with a body weight less 
than 2200g, in some with a body weight of 2200-3600g and in none with a body 
weight above 3600g. Vascular wall dimensions were below the resolution of the 
55MHz transducer in 20/50 brachial arteries and 14/50 femoral arteries. The 
abdominal aorta (depth 40-65mm) was unreachable with VHRU transducers 
(maximum penetrance 23mm) in all subjects.  
Results for intra-observer, inter-observer, and test-retest agreements are presented 
in Tables 5-7, with no bias and good agreement for all measured arterial dimension. 
There were only minute differences between inter-observer and test-retest 
agreements compared to intra-tester agreements. This suggested very limited 
operator dependency and technical variance overall influencing reproducibility of the 
measurements.(202) The technical variability was higher for smaller dimensions with 
measurements performed at a level bordering the axial resolution limit of the 
transducer. Overall, these results were similar to the results of study I.  
In a head-to-head comparison between CIMT measurements obtained using 
conventional HRU 12MHz and VHRU 35MHz transducers, the conventional 12MHz 
transducer was shown to grossly overestimate CIMT measurements among 
neonates. Our results for CIMT using VHRU (mean 0.17mm) were significantly lower 
than previously reported HRU-derived values (range 0.23-0.37 mm) and beyond the 
calculated axial resolution limit of > 0.25 mm for conventional HRU frequencies.(203-
206) We did not find any histological data on CIMT in this age group, but histologically 
measured IMT in infants has been reported as 0.40-0.50mm in the aorta and 0.05-
0.15mm in the coronary arteries.(21,24,39,207,208)  
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The results show that the axial resolution of conventional HRU frequencies is 
insufficient to measure CIMT in infants. VHRU, however, allow the non-invasive 
measurement of vascular wall layer dimensions of the carotid artery and proximal 
muscular arteries in neonates, whilst more distal arteries are too small precluding 
assessment with VHRU. The wall of the aorta is too deeply located to be visualized 
using VHRU, but the aortic IMT can be measured with the higher frequencies of the 
HRU-spectrum (10-20MHz) as previously reported.  
The main limitations of the study were the small sample size and lack of histological 
verification of vascular dimensions. We did however include neonates of different 
gestational ages and body-sizes and assessed multiple arteries using different 
transducer frequencies allowing us to assess the feasibility of VHRU in the neonatal 
age group over all. 
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Artery Dimension N Mean 
[mm] 
ΔMean (LOA 95%) 
[mm] 
CV% 
CCA (35 MHz) LD 38 2.619 0.000 (−0.107,0.107) 2.1 
IMT 40 0.158 −0.016 (−0.066, 0.035) 16.1 
BA (55 MHz) LD 40 1.445 −0.003 (−0.058, 0.052) 1.9 
IMT 24 0.062 −0.004 (−0.034, 0.026) 24.8 
IMAT 39 0.141 −0.013 (−0.064, 0.038) 18.5 
AT 25 0.085 −0.004 (−0.038, 0.031) 20.5 
FA (35–55 MHz) LD 37 1.794 −0.002 (−0.056, 0.053) 1.5 
IMT 37 0.068 −0.003 (−0.021, 0.014) 13.1 
IMAT 40 0.161 −0.013 (−0.066, 0.040) 16.8 
AT 32 0.092 0.004 (−0.042, 0.050) 25.6 
Table 5. Intra-observer variation for different neonatal arterial dimensions obtained 
with VHRU. ΔMean - mean difference; LOA 95% - 95% limits of agreement; CV% - 
coefficient of variation; CCA – common carotid artery ; BA – brachial Artery; FA – 
femoral artery; LD - lumen diameter; IMT - intima-media thickness; IMAT - intima-
media-adventitia thickness; AT - adventitia thickness. From Sundholm et.al. 2015 (II), 
used with permission from Elsevier.  
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Artery Dimension N Mean 
[mm] 
ΔMean (LOA 95%) 
[mm] 
CV% 
CCA (35 MHz) LD 38 2.556 0.065 (−0.053, 0.184) 2.4 
IMT 38 0.165 −0.012 (−0.054, 0.029) 12.8 
BA (55 MHz) LD 40 1.432 0.035 (−0.049, 0.118) 3.0 
IMT 24 0.062 −0.001 (−0.026, 0.025) 21.1 
IMAT 40 0.141 −0.000 (−0.039, 0.039) 14.3 
AT 25 0.087 0.003 (−0.028, 0.034) 18.1 
FA (35–55 MHz) LD 39 1.772 0.045 (−0.052, 0.142) 2.8 
IMT 36 0.066 −0.002 (−0.022, 0.017) 15.4 
IMAT 38 0.160 0.002 (−0.025, 0.029) 8.8 
AT 31 0.091 −0.002 (−0.040, 0.036) 21.2 
Table 6. Inter-observer variation for different neonatal arterial dimensions obtained 
with VHRU. ΔMean - mean difference; LOA 95% - 95% limits of agreement; CV% - 
coefficient of variation; CCA, common carotid artery; BA - brachial artery; FA - 
femoral artery; LD - lumen diameter; IMT - intima-media thickness; IMAT - intima-
media-adventitia thickness; AT - adventitia thickness. From Sundholm et.al. 2015 (II), 
used with permission from Elsevier. 
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Artery Dimension N Mean 
[mm] 
ΔMean (LOA 95%) 
[mm] 
CV% 
CCA (35 MHz) LD 10 2.671 0.103 (−0.352, 0.146) 4.8 
IMT 10 0.146 0.003 (−0.030, 0.036) 11.7 
BA (55 MHz) LD 10 1.417 0.076 (−0.145, 0.297) 8.0 
IMT 5 0.056 −0.004 (−0.022, 0.014) 16.0 
IMAT 10 0.113 −0.004 (−0.036, 0.028) 14.6 
AT 5 0.072 0.000 (−0.046, 0.046) 32.6 
FA (35–55 MHz) LD 10 1.769 0.002 (−0.190, 0.194) 5.6 
IMT 6 0.058 −0.002 (−0.09, 0.006) 7.1 
IMAT 10 0.144 0.003 (−0.028, 0.034) 10.9 
AT 6 0.087 −0.007 (−0.022, 0.036) 17.4 
Table 7. Test-retest variation for different neonatal arterial dimensions obtained with 
VHRU. ΔMean - mean difference; LOA 95% - 95% limits of agreement; CV% - 
coefficient of variation; CCA; BA – brachial artery; FA - femoral artery; LD - lumen 
diameter; IMT - intima-media thickness; IMAT - intima-media-adventitia thickness; 
AT - adventitia thickness. From Sundholm et.al. 2015 (II), used with permission from 
Elsevier. 
  
52 
 
4.3 VALIDATION OF ULTRASOUND ARTERIAL INTIMA THICKNESS 
MEASUREMENT  
Validation of VHRU IT and the four-line pattern 
The distinct four-line pattern in muscular artery VHRU was consistent with intimal 
thickening in histology (Figure 13a and b). A separation of the first echogenic zone 
(Z1-Z3) allowed the leading-to-leading edge measurement of the intima thickness.  
 
Figure 13. Schematic, 55MHz VHRU-derived image, and corresponding histology of 
temporal arteries with evident intimal thickening. Leading edge borders are shown. 
IT – Intima; MT – Media; AT – Adventitia; IEL – Internal elastic laminae. Modified from 
Sundholm et.al. 2019 (III). 
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Arterial layer thickness measurements of the first region (Z1-Z3) agreed well with 
histological IT and showed good intra- and inter-observer agreements. (Table 8-10). 
The four-line pattern was detected in 28/29 patients with histological IT>0.06mm 
and in none with thinner intima (sensitivity of 96.3%, CI95%: 81.0-99.9% and a 
specificity of 100%, CI95%: 66.3-100%). We did not find any significant difference in 
accuracy between the two ultrasound systems used (Vevo770 vs. VevoMD, ICC 0.867, 
CI95% 0.603-0.955 and 0.971 CI95% 0.901-0.992, respectively), with a trend for 
reduced accuracy for images of lower quality (CV% 12.8 vs. 23.6 p=0.098). 
Table 8. Comparison of histology and VHRU measurements of intima and intima-
media thickness. SD -standard deviation; LOA – 95% limits of agreement; CV% - 
coefficient of variation (%); CI95% – 95% confidence interval; ΔMean – mean 
difference; IT – Intima thickness; IMT – Intima-media thickness. From Sundholm et.al. 
2019 (III), used with permission from Elsevier. 
 
 
Intra-observer 
  
N 
  
Mean 
[mm]  
SD 
[mm] 
ΔMean 
[mm]  
LOA 95% 
  
CV% 
  
IT  25 0.140 0.047 -0.011 -0.053; 0.032 15.7 
IMT  31 0.246 0.090 -0.006 -0.085; 0.071 16.1 
Table 9. Intra--observer agreements for VHRU-derived intima and intima-media 
thicknesses. SD – standard deviation; LOA95% - 95% limits of agreement; CV% - 
Coefficient of variation (%); CI95% – 95% confidence interval; IT- Intima thickness; 
IMT – Intima-media thickness. From Sundholm et.al. 2019 (III), used with permission 
from Elsevier. 
  
  Histology VHRU    
 N  
Mean 
[mm] 
SD 
[mm] 
Mean 
[mm] 
SD 
[mm] 
ΔMean 
[mm] LOA 95%  CV%  
IT 28 0.125 0.045 0.132 0.050 0.007 -0.042;0.057 19.7 
IMT 37 0.255 0.097 0.243 0.086 -0.012 -0.086;0.064 15.1 
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Inter-observer 
 
 
N 
 
 
Mean 
[mm]  
SD 
[mm] 
ΔMean 
[mm]  
LOA 95% 
 
 
CV% 
 
 
IT  25 0.136 0.044 0.012 -0.040;0.065 19.9 
IMT  31 0.240 0.085 0.025 -0.075;0.125 21.2 
Table 10. Inter-observer agreements for VHRU-derived intima and intima-media 
thicknesses. SD – standard deviation; LOA95% - 95% limits of agreement; CV% - 
Coefficient of variation (%); CI95% – 95% confidence interval; IT- Intima thickness; 
IMT – Intima-media thickness. From Sundholm et.al. 2019 (III), used with permission 
from Elsevier. 
 
Measurements leading-to-trailing edge of the first echogenic zone (Z1-Z3) in subjects 
without a visible four-line pattern was not associated with histological IT (Figures 14 
and 15). This is in line with previous validation attempts in arteries with healthy thin 
IT.(18,89) Leading-to-trailing edge measurements of IT in arteries with thickened IT, 
however, correlates well with histological IT, but systematically overestimates the 
dimension, an issue not seen with the leading-to-leading edge method.(69)  
 
Figure 14. Bland-Altmant plots comparing very-high resolution ultrasound (VHRU) 
intima layer thickness (IT) with histology IT using the leading-to-trailing edge 
measurement technique in the assessment of the VHRU image. a) Leading-to-trailing 
edge VHRU measurement of blood-intima interface (fused zones 1-3) in arteries with 
histological IT less than 0.06 mm. b) Leading-to-trailing edge VHRU measurement of 
the visible IT (zones 1-3 separated in image, measurement from leading-edge of zone 
1 to trailing edge of zone 3) in arteries with histological IT 0.06 mm or more. Note the 
systematic bias in leading-to-trailing edge VHRU IT measurement in comparison to 
histological IT in both settings. From the supplemental material of Sundholm et.al. 
2019 (III), used with permission from Elsevier. 
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Figure 15. Schematic image of how measures using the leading-to-trailing edge 
method induces bias in a) vessels with a thickened intima (separated zones 1-3). and 
b) vessels with a thin intima (fused zones 1-3). Note how the bias is equal to Z3 in case 
a). whereas the bias is influenced by the histological intima artery layer thickness (IT) 
in b) as Z1-Z3 remains constant and non-related with histological IT variance. From 
the supplemental material of Sundholm et.al. 2019 (III) used with permission from 
Elsevier. 
 
We conclude that VHRU-derived measurements of intima-thickness is accurate and 
reliable in arteries with an intimal thickness of >0.06mm corresponding to 5px with 
the 55MHz transducer. We further showed that the four-line pattern is increasing 
with age with 76% of the subjects aged 40 to 86 years showing a four-line pattern in 
the temporal artery and 68% in the radial artery in vivo using the highest 50-55 MHz 
ultrasound frequency. The four-line pattern was not visible in most carotid and 
brachial arteries, likely related to the lower 30-35 MHz ultrasound frequencies used 
for these anatomical locations for imaging depth reasons. We further preliminarily 
show that arterial IT in our sample is related to cardiovascular risk factors (Table 11). 
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These results suggest that the VHRU-derived vascular IT could be used to monitor 
vascular health and potentially as a non-invasive surrogate marker of cardiovascular 
disease in the aging population. 
Table 11. Linear regression model assessing effects of age and cardiovascular risk 
factors on histological intima thickness in the GCA sample (n=37). From the 
supplemental material of Sundholm et.al. 2019 (III), used with permission from 
Elsevier. 
 
The study was limited by histological verification of temporal arteries only. The study 
setting did, however, allow the direct comparison of in vivo VHRU measurements 
with histology in subjects with a wide range of vascular aging, spanning from a thin 
intima below axial resolution to pathological intimal thickening bordering early 
plaque formation. We further assessed vascular morphology using VHRU in multiple 
arteries and verified the presence of the four-line pattern in radial arteries to a similar 
extent as in temporal arteries. 
  
Dependent variable Adjusted R2 Model p-value 
Intima thickness [μm] 0.404 <0.001 
Independent variables Beta p-value 
Constant -36.6 0.464 
Age [years] 1.7 0.038 
Hypertension [yes=1 no=0] 42.2 0.020 
Diabetes [yes=1 no=0] 34.2 0.044 
Hypercholesterolemia [yes=1 no=0] -26.7 0.141 
Smoking [10 pack years] 6.8 0.069 
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4.4 DIAGNOSTIC UTILITY OF VHRU IN GIANT-CELL ARTERITIS
VHRU-derived intima thickness measurements and HRU-derived Halo-Doppler ratio 
(HDR) in the transmural inflammation GCA group differed significantly from GCA 
negative subjects and from clinical GCA patients with no or limited inflammation on 
histology, and without histological arterial wall layer thickening. (Table 12)   
Specificity and sensitivity charts provided optimal diagnostic cut-off values for TMI 
>0.30mm for IT and 2.0 for HDR, yielding  sensitivity 90.9%, CI95% 58.7-99.8%; 
specificity 100%, CI95% 91.1-100.0%; LHR+ N/A; LHR- 0.1 for IT and sensitivity 55.6%, 
CI95% 21.2-86.3%; specificity 93.5%, CI95% 77.9-99.1%; LHR+ 8.6, LHR- 0.5 for HDR, 
compared to the non-GCA group. 
To assess diagnostic utility, the coded images were analysed by a second expert 
observer blinded to patient characteristics and biopsy results. Inter-observer 
agreements for diagnostic cut-off values were high (Cohen’s Kappa: 0.873 for 
IT>0.3mm and 0.811 for HDR>2.0). ROC analysis showed good diagnostic utility for 
both IT measurements and HDR (AUC: VHRU-IT 0.99, CI95% 0.97-1.00; HRU-HDR 
0.75, CI95% 0.54-0.96, p=0.026), with VHRU-derived IT outperforming HDR.  
The diagnostic utility of HDR was found to be limited in subjects who had received 
glucocorticoid treatment for more than 5 days (Figure 16a). This is in line with 
previously published data.(164) In contrast, VHRU derived IT did not seem to be 
impacted by glucocorticoid treatment response to the same extent, and IT remained 
thickened for up to 37 day after treatment initiation (Figure 16b). The vascular wall 
of subjects with shorter duration of glucocorticoid treatment was fairly echolucent, 
making dimension borders challenging to distinguish (Figure 17). The results suggest 
that VHRU could be beneficial in GCA patient follow-up during glucocorticoid 
treatment in the outpatient setting.  
 
  
58 
 
Study group 
Non-GCA 
N = 40 
GCA, Biopsy 
negative 
N = 15 
GCA, 
Inflammation 
limited to 
adventitia (ILA) 
N = 9 
GCA, transmural 
inflammation 
(TMI) 
N = 11 p-value 
HRU; N 31 9 7 9  
Halo 5 (16%) 1 (11%) 2 (29%) 5 (56%) 0.083 
HDR 1.4 (1.0-2.8) 1.4 (1.2-1.9) 1.4 (1.0-4.2) 2.4 (1.5-9.3) a 0.007 
HDR > 2.0 2 (6%) 0 (0%) 2 (29%) 5 (56%)a 0.003 
VHRU; N  40 15 9 11  
Measurable IT; N 31 9 9 11  
Mean IT [mm] 0.12 (0.06-0.23) 0.09 (0.06-0.14) 0.14 (0.06-0.22) 0.28 (0.06-0.53) <0.001 
Max IT [mm] 0.16 (0.06-0.28) 0.11 (0.08-0.28) 0.16 (0.08-0.25) 0.40 (0.06-0.70) a <0.001 
Max IT > 0.30mm 0 (0%) 0 (0%) 0 (0%) 10 (91%)a <0.001 
IMT; N 40 15 9 11  
IMT [mm] 0.22 (0.08-0.42) 0.22 (0.09-0.29) 0.23 (0.17-0.28) 0.55 (0.22-0.834) a <0.001 
Max IMT [mm] 0.27 (0.09-0.49) 0.26 (0.10-0.43) 0.28 (0.18-0.55) 0.69 (0.31-1.10) <0.001 
Histology; N 37 12 9 11 
 
IT [mm] 0.11 (0.01-0.24) 0.09 (0.02-0.18) 0.14 (0.08-0.19) 0.38 (0.04-0.90) a <0.001 
MT [mm] 0.16 (0.05-0.36) 0.16 (0.08-0.25) 0.17 (0.11-0.34) 0.20 (0.11-0.41) 0.442 
IMT [mm] 0.28 (0.07-0.49) 0.24 (0.10-0.41) 0.27 (0.24-0.50) 0.62 (0.15-1.31) a <0.001 
AT [mm] 0.06 (0.02-0.12) 0.06 (0.03-0.08) 0.07 (0.05-0.14) 0.14 (0.05-0.23) a <0.001 
Table 12. Halo-Doppler ratio and vascular dimensions obtained with VHRU and 
histology. Results are presented as median (range) or N (%). P-values represent 
results for group comparisons with the Fisher-Freeman-Halton exact test (post-hoc: 
independent Fisher exact test with Bonferroni adjusted significance levels) and the 
Kruskal-Wallis tests (post-hoc: Dunn-Bonferroni). Note that IT was not measurable in 
VHRU imaged in subjects with IT<0.06mm. a – differs significantly from all other 
groups in post-hoc analysis at level p<0.05; IT – intima thickness; MT – media 
thickness; IMT – intima-media thickness; AT – adventitia thickness; VHRU – very-high 
resolution ultrasound; HRU – high resolution ultrasound; HDR – Halo-Doppler Ratio. 
From Sundholm et al. 2019 (IV).  
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Figure 16 a) Conventional ultrasound derived Halo-Doppler ratio versus 
glucocorticoid-treatment duration prior to imaging in the transmural inflammation 
(TMI) group. b) VHRU intima thickness versus glucocorticoid-treatment duration prior 
to imaging in TMI group. Note that the intimal thickness exceeds the diagnostic cut-
off 0.3mm from 5 days of corticosteroid treatment, whereas the prevalence of the 
halo-sign cut-off >2.0 diminishes. HDR – Halo-Doppler ratio; HRU – Highresolution 
ultrasound; VHRU – Very-high resolution ultrasound. Modified from Sundholm et.al. 
2019 (IV). 
 
 
 
Figure 17. Very-high resolution ultrasound image (50MHz) of a temporal artery with 
transmural inflammation after only 2 days of glucocorticoid treatment. Note the thick 
and dark vascular wall making the layer borders challenging to distinguish. IT – intima 
thickness; MT – media thickness. Modified from Sundholm et.al. 2019 (IV). 
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Neither HDR or VHRU-IT showed any diagnostic utility in groups with limited or no 
inflammation on histology and a thin histological IT. This is in line with previous 
findings showing decreased diagnostic utility of the halo sign in this patient 
group.(153) The increased resolution of VHRU did not add further diagnostic value 
to these subjects. 
The main limitation of this study is the evident delay in ultrasound assessment, with 
imaging performed, in many cases, following several days of glucocorticoid 
treatment. This most likely affected the diagnostic utility of the halo-sign, reducing 
comparability with previous studies, but allowed a direct comparison of VHRU 
images and histology.  
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5. CONCLUSIONS
 
I. The use of a semi-automatic border detection software is, feasible, 
accurate and precise for very-high resolution ultrasound image analysis of 
arterial intima-media thickness and adventitia thickness, with reduced 
analysis time compared to electronic calipers. 
 
II. The arterial wall layer thickness in infants is below the axial resolution, 
and thus unmeasurable, using conventional high-resolution ultrasound 
frequencies. The increased resolution of very-high resolution ultrasound 
allows accurate and precise non-invasive measurements of the carotid 
intima-media thickness, in addition to brachial and femoral arterial 
intima-media thickness and adventitia thickness in neonates in vivo.  
 
III. The identification of a distinct four-line pattern with very-high resolution 
ultrasound imaging of the arterial far wall allows the non-invasive 
quantification of intima layer thickness in superficial arteries of the aging 
population. The finding is consistent with changes in the intima occurring 
with arterial aging. 
 
IV. Very-high resolution ultrasound derived measurements of temporal 
artery intima layer thickness allows the non-invasive real time diagnosis 
of transmural inflammation related intimal thickening of the temporal 
artery in patient with suspected giant cell arteritis. The very-high 
resolution ultrasound detected vascular wall thickening was evident in 
most patients with transmural inflammation, and this diagnostic marker 
is more sensitive than the conventional high-resolution ultrasound 
derived Halo-Doppler-ratio in patients with prolonged glucocorticoid 
treatment. Neither the VHRU-method nor the Halo-Doppler ratio showed 
diagnostic utility in patients with no inflammation or inflammation limited 
to the adventitia on histology. 
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6. PERSPECTIVES AND FUTURE RESEARCH TOPICS
 
This thesis presents very-high resolution ultrasound as a tool to investigate vascular 
morphology and pathology in vivo. We show that the increased resolution allows for 
assessment of vascular structure in almost microscopical detail. This provides the 
opportunity for a new field of different research topics.  
Most previous studies assessing distal vascular morphology in different age groups 
are based on post-mortem data, and thus limited sample sizes. This emerging 
method allows for investigation and follow-up of larger populations. It is now 
possible to non-invasively assess factors related with vascular morphology, 
pathology, and changes in vascular structures with aging. This is an interesting new 
field of research that could give us further knowledge on vascular health and 
diseases.  
Carotid intima-media thickness has been used as a surrogate marker for 
cardiovascular risk for three decades. The method isn’t flawless, and the utility is 
limited in a clinical setting.(7) The increased resolution of very-high resolution 
ultrasound provides more detailed information of the vascular wall than the 
established high-resolution ultrasound method, and the increased resolution could 
also improve measurement accuracy and reduce absolute measurement errors. 
Future research topics could address not only peripheral conduit artery intima-media 
thickness, but also intima thickness in relation to cardiovascular risk.  
The non-invasive nature and versatility of conventional ultrasound has established 
its role as a diagnostic tool in peripheral artery disease.(209) The method is, however, 
limited when studying the smallest arteries due to limited resolution. Further 
research could assess the utility of VHRU when assessing severity of peripheral artery 
disease.  
Our results indicate that, compared with HRU, VHRU used as a diagnostic tool to 
assess suspected giant cell arteritis of the temporal artery could be more sensitive 
for patients with several days of ongoing glucocorticoid treatment. Current 
guidelines state that imaging should be performed prior to or during the first days of 
63 
 
treatment.(172) Further studies should compare VHRU and HRU methods in a 
pretreatment setting. Another interesting topic would be to assess the utility of 
VHRU as method to non-invasively and prospectively monitor changes in the vascular 
wall in response to treatment. 
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7. YHTEENVETO (FINNISH SUMMARY)
 
Kajoamaton korkeataajuusultraääni (VHRU, very-high resolution ultrasound, 25-
55MHz) on 2000-luvulla kehitetty ultraäänimenetelmä valtimonseinämän 
kuvantamiseen. Korkeammilla ultraäänitaajuuksilla kuvan erottelukyky on parempi, 
lähes mikroskooppitasoa, mutta kuvausalue on rajoittunut lähellä anturia oleviin 
rakenteisiin. Menetelmä soveltuu erinomaisesti aikuisten pinnallisten valtimoiden ja 
lasten pienten valtimoiden valtimoseinämän kajoamattomaan kuvantamiseen.  
Tässä väitöskirjassa arvioidaan puoliautomaattisen analyysiohjelman käyttöä 
valtimoseinämän eri kerrosten mittaamisessa. Lisäksi kirjassa selvitetään 
menetelmän soveltuvuutta vastasyntyneiden lasten valtimoseinämän arvioinnissa, 
menetelmän käyttöä valtimon sisäkalvon (tunica intima) paksuuden mittauksessa 
ikääntyneillä, sekä menetelmän hyötyjä jättisoluarteriitin diagnostiikassa.  
Tutkimme puoliautomaattisen ohjelman (AMS, arterial measurement systems) 
käyttöä kymmenen henkilön eri verisuonista otettujen kuvien arvioinnissa 
vertailemalla analyysiaikaa ja mittauksien luotettavuutta käsin tehtyihin 
yksittäismittauksiin. Emme löytäneet eroa menetelmien luotettavuudessa, mutta 
puoliautomaattisen menetelmän analyysiaika oli merkittävästi lyhyempi. Mittausten 
suhteellinen tekninen vaihtelu liittyi lähinnä kuvanlaatuun ja mitattavaan 
etäisyyteen. 
Vertasimme kymmenestä vastasyntyneestä VHRU-menetelmällä ja tavallisella 
ultraäänellä otettuja kuvia. VHRU-menetelmä pystyi luotettavasti ja tarkasti 
mittaamaan suurten ja keskisuurten valtimoiden seinämän kerrospaksuudet, mutta 
tavallisen ultraäänen erottelukyky ei ollut riittävä. VHRU-menetelmän erottelukyky 
ei ollut riittävä pienempien ääreisvaltimoiden, esimerkiksi värttinävaltimon, 
seinämän kerrosten arvioinnissa.  
VHRU-menetelmällä tutkittiin 78 ikääntynyttä potilasta, jotka oli lähetetty 
ohimovaltimon koepalan ottoon jättisoluarteriittiepäilyn takia. Niiden potilaiden 
joukossa, joilla ei ollut tulehdusmuutoksia suonen seinämässä (biopsia-negatiiviset), 
76 %:lla oli histologisesti paksuuntunut valtimon sisäkalvo (tunica intima), joka oli 
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tarkasti ja luotettavasti mitattavissa VHRU-menetelmällä. Jättisoluarteriittipotilailla 
ohimovaltimon seinämä oli histologiassa selkeästi paksuntunut. VHRU-menetelmällä 
mitattu yli 0.3 mm:n valtimon sisäkalvo oli tarkka ja herkkä mittari jättisoluarteriitille, 
ja se oli todettavissa 10/11 potilaalla.   
Kajoamaton korkeataajuusultraääni on uusi menetelmä, jolla pinnallisten 
valtimoiden seinämän kerrosten paksuudet voidaan tarkasti ja luotettavasti mitata. 
Puoliautomaattisella ohjelmalla valtimoseinämän kerroksen paksuuden mittaamista 
voidaan nopeuttaa. Menetelmän parempi erottelukyky mahdollistaa pienten 
vastasyntyneiden valtimoseinämän kuvantamisen ja ikääntyvien valtimon sisäkalvon 
(tunica intima) paksuuden mittaamisen. Ohimovaltimon jättisoluarteriitissa 
suonenseinämä turpoaa tulehduksen seurauksena ja tämä näkyy VHRU-kuvissa 
paksuuntuneena sisäkalvona (tunica intima). Menetelmä voisi tulevaisuudessa 
soveltua kliiniseen käyttöön pinnallisten verisuonisairauksien tutkimuksessa ja 
diagnostiikassa.   
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8. SAMMANFATTNING (SWEDISH SUMMARY)
 
Icke-invasivt högresolutionsultraljud (VHRU, very-high resolution ultrasound) är en 
ny under 2000-talet utvecklad metod för undersökning av kärlväggen. Den höga 
ultraljudsfrekvensen ger en bättre, nästan mikroskopisk, resolution i ultraljudsbilden, 
men den lämpar sig endast för avbildning av närliggande strukturer. Med metoden 
kan den ytliga artärväggens olika skikt och små barns artärer avbildas. I den här 
avhandlingen utreder vi möjligheten att i ultraljudsbilden mäta artärväggens 
skikttjocklek med hjälp av en halvautomatisk metod. Vi utreder dessutom 
möjligheten att undersöka artärväggen hos nyfödda barn, att mäta artärväggens 
innersta lagrets (tunica intima) tjocklek hos den åldrande populationen, samt utreder 
nyttan av VHRU vid diagnostik av misstänkt jättecellsarterit.  
Vi tillämpade ett halvautomatiskt analysprogram (AMS, arterial measurement 
systems) på VHRU-bilder tagna från ytliga artärer från tio personer och jämförde 
analystiden samt pålitligheten (precisionen) av de halvautomatiska mätningarna 
med enskilda manuella mätningar. Pålitligheten var jämförbar men analystiden var 
signifikant kortare. Pålitligheten var främst relaterad till bildkvaliteten och det 
uppmätta avståndet. 
Vi jämförde bilder av ytliga muskulära artärer hos tio nyfödda barn och prematurer 
tagna med både VHRU-metoden och konventionellt ultraljud. VHRU-metoden kunde 
noggrant och pålitligt mäta artväggens skikttjocklek i stora och medelstora artärer 
medan det konventionella ultraljudets resolution var otillräckligt. VHRU-metodens 
resolution var otillräcklig för bedömning av artärväggens skikttjocklek i mindre och 
mera perifera kärl så som i strålbensartären.      
Vi undersökte tinningartären med VHRU-metoden hos 78 äldre patienter 
remitterade för biopsi av tinningartären på grund av misstänkt jättecellsarterit. Bland 
patienter utan histologiskt påvisbar inflammation i artärväggen (negativ biopsi) 
konstaterades ett åldersrelaterat förtjockat inre skikt (tunica intima) hos 76% som 
noggrant och pålitligt kunde mätas i ultraljudsbilden. Ett förtjockat inre skikt (tunica 
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intima), mer än 0,3 mm i ultraljudsbilden, var ett specifikt och sensitivt fynd för 
jättecellsarteriten, och kunde konstateras hos 10/11 patienter.    
Sammanfattningsvis är högresolutionsultraljud en ny metod för icke-invasiv 
undersökning av ytliga artärers kärlvägg. Tillämpningen av ett halvautomatiskt 
program i bildanalysen var pålitligt och försnabbade analysprocessen. Metodens 
höga resolution möjliggör avbildning av den ytliga artväggen hos nyfödda samt en 
mätning av ett förtjockat inre skikt (tunica intima) i artärväggen i den åldrande 
populationen. Jättecellsarterit av tinningartären ger upphov till en uppsvullen 
kärlvägg och det kraftigt förtjockade inre skiktet (tunica intima) kan icke-invasivt 
mätas med VHRU vid misstänkt jättecellsarterit. Metoden kan i framtiden få en viktig 
roll inom den kliniska diagnostiken av ytlig vaskulärpatologi och i studier av vaskulärt 
åldrande. 
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